The following content is considered nonlegal and nonbinding OPINION only, and does not legally assume any entity is responsible for the accuracy of any facts that may seem to be presented by any entity. Rather this is meant to be a starting point of research into the facts or truth. The standard of the reasonable person should be assumed with regard to any possible research into the facts or truth!
The FDA gets paid to review clinical trials.
Only slight improvement over not taking a drug is required by the FDA.
Dosage does not need to be the same in a clinical trial comparison of drugs.
A drug can be compared to a placebo.
Patient names, results can be false if not caught by the government.
Most research on FDA approved drugs was done by government institutions.
Most molecules for new drugs tend to resemble molecules for drugs that currently exist or part of a molecule of a drug that currently exists reviewed in clinical trial or studies.
There are few innovative drugs, biologicals, or clinical trials.
Even government researchers are not properly or completely monitored by the government, lawmakers, justice system for improper associations with drug companies.
Clinical trials tend to be done for what appears to be marketable, even for vague illnesses.
Clinical trails tend to be done for what can be considered a treatment and not a cure; the word treatment can tend to have a strange or frightening meaning.
New Clinical trials for old drugs can reveal that the old Clinical trial may seem to have been poor science, or not properly planned, or that the drug actually increased the symptomology it was to reduce, and data about harm to children can be suppressed.
New Clinical trials for old drugs nearing losing patent protection may suggest that the old drug can be more effective than the drug with patent protection.
Clinical trials now may seem to be controlled by those most likely to benefit from favorable results of the trial.
Even academic institutions seem to have lost independent researcher status regarding clinical trials.
Even government researcher's motives may be compromised by financial deals with drug companies, and often those deals can occur after a clinical trial, and can be difficult to back track or investigate.
Bias can be built in to a Clinical trial by: (1) enrolling young subjects who tend to have less side effects, (2) presenting incomplete data, method of administration of the drug, (3) being too short to have any meaning (only 6 weeks), (4) by too low of a dose to have any meaning, (5) an onset of averages of responses which could be very skewed by certain patients, and (6) not being done often enough by nonprofit entities.
Placebos can be about as effdctive as a drug, and can be just two points out of about 62 in a scale different than a drug.
Clinical trials environmental benefits can make a drug seem of greater benefit, and in the past research subjects seem happy to have any attention paid to them.
Clinical trials have been done in the past on uninformed persons who may be institutionalized or who have few resources.
Someone recently died during a Clinical trial.
Laws may need to be changed respectively regarding informed consent, or knowing the risks for a Clinical trial or study, experiment, or research project regarding a drug or biological (often a hormone), or any unusual or unnatural agent introduced into the body or environment.
Most television and movies have done a great deal to get the public to trust doctors and medicine.